Methods and uses of TIE2 binding and/or activating agents
US9186390B2 · kind B2 · utility
2Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2011 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | Jun 6, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/475
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods and uses of Tie2 binding and/or activating agents. In particular, the present disclosure provides methods and uses for inhibiting the expansion of colony forming unit-granulocytes, reducing eosinophils and/or basophils, for treating allergic disease or response or eosinophil/basophil associated condition and for reducing inflammatory cytokine and/or chemokine levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.